Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuma Nagata

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Frontiers in Pharmacology|December 16, 2020
Effectiveness of Pharmacist-Physician Collaborative Management for Patients With Idiopathic Pulmonary Fibrosis Receiving PirfenidoneYukari Satsuma, Hiroaki Ikesue, Kaori Kusuda, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 24, 2017
Early Immune-Related Adverse Events and Association with Outcome in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab: A Prospective Cohort StudyShunsuke Teraoka, Daichi Fujimoto, Takeshi Morimoto, et al.
The European Respiratory Journal|October 18, 2014
Analysis of advanced lung cancer patients diagnosed following emergency admissionDaichi Fujimoto, Ryoko Shimizu, Takeshi Morimoto, et al.
Anticancer Research|January 10, 2014
Bevacizumab plus weekly paclitaxel with or without carboplatin for previously-treated non-squamous non-small cell lung cancerAkito Hata, Nobuyuki Katakami, Kosuke Tanaka, et al.
Internal Medicine (Tokyo, Japan)|June 3, 2014
Prognostic value of bronchoalveolar lavage in patients with non-HIV pneumocystis pneumoniaKoji Tamai, Ryo Tachikawa, Keisuke Tomii, et al.
BMC Pulmonary Medicine|May 7, 2026
Long-term prognostic impact of clinical frailty scale on acute exacerbation of fibrotic interstitial lung disease: a retrospective cohort studyShoichiro Saito, Chigusa Shirakawa, Kanji Yamada, et al.
Respiratory Investigation|March 8, 2023
Longitudinal changes in mental health outcomes after COVID-19 hospitalization: A prospective studyChigusa Shirakawa, Ryo Tachikawa, Ryohei Yamamoto, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 14, 2017
Predictive Performance of Four Programmed Cell Death Ligand 1 Assay Systems on Nivolumab Response in Previously Treated Patients with Non-Small Cell Lung CancerDaichi Fujimoto, Yuki Sato, Keiichiro Uehara, et al.
Clinical & Experimental Metastasis|April 1, 2014
Features and prognostic impact of distant metastasis in patients with stage IV lung adenocarcinoma harboring EGFR mutations: importance of bone metastasisDaichi Fujimoto, Hiroyuki Ueda, Ryoko Shimizu, et al.
Scientific Reports|September 14, 2017
Alteration of PD-L1 expression and its prognostic impact after concurrent chemoradiation therapy in non-small cell lung cancer patientsDaichi Fujimoto, Keiichiro Uehara, Yuki Sato, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Frontiers in Pharmacology|December 16, 2020
Effectiveness of Pharmacist-Physician Collaborative Management for Patients With Idiopathic Pulmonary Fibrosis Receiving PirfenidoneYukari Satsuma, Hiroaki Ikesue, Kaori Kusuda, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 24, 2017
Early Immune-Related Adverse Events and Association with Outcome in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab: A Prospective Cohort StudyShunsuke Teraoka, Daichi Fujimoto, Takeshi Morimoto, et al.
The European Respiratory Journal|October 18, 2014
Analysis of advanced lung cancer patients diagnosed following emergency admissionDaichi Fujimoto, Ryoko Shimizu, Takeshi Morimoto, et al.
Anticancer Research|January 10, 2014
Bevacizumab plus weekly paclitaxel with or without carboplatin for previously-treated non-squamous non-small cell lung cancerAkito Hata, Nobuyuki Katakami, Kosuke Tanaka, et al.
Internal Medicine (Tokyo, Japan)|June 3, 2014
Prognostic value of bronchoalveolar lavage in patients with non-HIV pneumocystis pneumoniaKoji Tamai, Ryo Tachikawa, Keisuke Tomii, et al.
BMC Pulmonary Medicine|May 7, 2026
Long-term prognostic impact of clinical frailty scale on acute exacerbation of fibrotic interstitial lung disease: a retrospective cohort studyShoichiro Saito, Chigusa Shirakawa, Kanji Yamada, et al.
Respiratory Investigation|March 8, 2023
Longitudinal changes in mental health outcomes after COVID-19 hospitalization: A prospective studyChigusa Shirakawa, Ryo Tachikawa, Ryohei Yamamoto, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 14, 2017
Predictive Performance of Four Programmed Cell Death Ligand 1 Assay Systems on Nivolumab Response in Previously Treated Patients with Non-Small Cell Lung CancerDaichi Fujimoto, Yuki Sato, Keiichiro Uehara, et al.
Clinical & Experimental Metastasis|April 1, 2014
Features and prognostic impact of distant metastasis in patients with stage IV lung adenocarcinoma harboring EGFR mutations: importance of bone metastasisDaichi Fujimoto, Hiroyuki Ueda, Ryoko Shimizu, et al.
Scientific Reports|September 14, 2017
Alteration of PD-L1 expression and its prognostic impact after concurrent chemoradiation therapy in non-small cell lung cancer patientsDaichi Fujimoto, Keiichiro Uehara, Yuki Sato, et al.
Pageof 8